Carbylan Therapeutics raises $65M in IPO, stock rises on debut

Carbylan Therapeutics raised $65 million in an IPO Thursday after a two-month delay in which it trimmed its targets a bit...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.